Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite

Bone Mineral Density and Lipid Changes During 5 Years of Follow-up in a Study of Prevention of Breast Cancer with Toremifene in Healthy, High-risk Pre- and Post-menopausal Women

By Erkkola R.  

Breast Cancer Research and Treatment, Vol. 93, Iss. 3, 2005-10 ,pp. : 277-287

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen Added to Adjuvant Chemotherapy in Premenopausal Women with Early Breast Cancer: is it Standard Practice or Still a Subject for Study?

By Bramwell V.H.C.   Pritchard K.I.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1625-1627

Elsevier

Access to resources Recommend Favorite

Estrogen deficiency and bone loss in women with breast cancer

By Shapiro Charles  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 815-818

Springer Publishing Company

Access to resources Recommend Favorite

Changes on Bone Mineral Density after Adjuvant Treatment in Women with Non-metastatic Breast Cancer

By Rodríguez-Rodríguez Luz-Milva   Rodríguez-Rodríguez Eva-María   Oramas-Rodríguez Juana-María   Santolaria-Fernandez Francisco   Llanos Marta   Cruz Josefina   Martínez Antonio   González-Reimers Emilio   Gómez Angeles   Batista Norberto  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 75-83

Springer Publishing Company

Access to resources Recommend Favorite